Antipsychotic properties of loxapine succinate.
D002389:Catatonia / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010078:Oxazines / Q000009:adverse effects; D010259:Paranoid Disorders / Q000188:drug therapy; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003989:Dibenzoxazepines; D010078:Oxazines; D014149:Tranquilizing Agents